Skip to main content
OpenTrials

Clinical trial condition

Small Cell Lung Carcinoma

Explore clinical trials studying Small Cell Lung Carcinoma. Study availability and eligibility vary by location and protocol.

820 public trials 196 recruiting studies
Refine in advanced search Browse all conditions

Small Cell Lung Carcinoma trial results

Active, Not Recruiting

A French Real-life Study: EvaluatioN of durvALumab Utilization and Effectiveness for First Line Extensive Stage Small Cell Lung Cancer.

NCT05683977

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Lung Diseases, +7 more
Locations
  • Research Site Angers, France
  • Research Site Argenteuil, France
  • Research Site Avignon, France
  • Research Site Avignon, France
View all 34 locations
View Trial Details
Active, Not Recruiting

S1827 (MAVERICK) Testing Whether the Use of Brain Scans Alone Instead of Brain Scans Plus Preventive Brain Radiation Affects Lifespan in Patients With Small Cell Lung Cancer

NCT04155034

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Extensive Stage Lung Small Cell Carcinoma, +10 more
Locations
  • University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
  • Katmai Oncology Group Anchorage, Alaska, United States
  • Fairbanks Memorial Hospital Fairbanks, Alaska, United States
  • University of Arizona Cancer Center-Orange Grove Campus Tucson, Arizona, United States
View all 446 locations
View Trial Details
Active, Not Recruiting

Testing the Addition of an Anti-cancer Drug, BAY 1895344, to Usual Chemotherapy for Advanced Stage Solid Tumors, With a Specific Focus on Patients With Small Cell Lung Cancer, Poorly Differentiated Neuroendocrine Cancer, and Pancreatic Cancer

NCT04514497

Conditions
Adenocarcinoma, Bronchial Neoplasms, Carcinoma, +38 more
Locations
  • Mayo Clinic Hospital in Arizona Phoenix, Arizona, United States
  • UC Irvine Health/Chao Family Comprehensive Cancer Center Orange, California, United States
  • Yale University New Haven, Connecticut, United States
  • Smilow Cancer Hospital Care Center-Trumbull Trumbull, Connecticut, United States
View all 23 locations
View Trial Details
Active, Not Recruiting

Study of JANX008 in Subjects With Advanced or Metastatic Solid Tumor Malignancies

NCT05783622

Conditions
Adenocarcinoma, Breast Diseases, Breast Neoplasms, +46 more
Locations
  • City of Hope Medical Center Duarte, California, United States
  • University of California, Davis Comprehensive Cancer Center Sacramento, California, United States
  • University of California San Diego Moores Cancer Center San Diego, California, United States
  • Winship Cancer Institute, Emory University Atlanta, Georgia, United States
View all 18 locations
View Trial Details
Active, Not Recruiting

Safety and Efficacy Study of Investigational Agents as Monotherapy or in Combination With Pembrolizumab (MK-3475) for the Treatment of Extensive-Stage Small Cell Lung Cancer (ES-SCLC) in Need of Second-Line Therapy (MK-3475-B98/KEYNOTE-B98)

NCT04938817

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Lung Diseases, +8 more
Locations
  • Banner MD Anderson Cancer Center ( Site 0152) Gilbert, Arizona, United States
  • Northside Hospital-Northside Hospital Oncology Network ( Site 0156) Atlanta, Georgia, United States
  • Parkview Research Center at Parkview Regional Medical Center ( Site 0180) Fort Wayne, Indiana, United States
  • Baptist Health Lexington-Research ( Site 0158) Lexington, Kentucky, United States
View all 48 locations
View Trial Details
Active, Not Recruiting

Testing the Combination of the Anti-cancer Drugs XL184 (Cabozantinib) and Nivolumab in Patients With Advanced Cancer and HIV

NCT04514484

Conditions
Adenocarcinoma, Adnexal Diseases, Advanced Differentiated Thyroid Gland Carcinoma, +141 more
Locations
  • Northwestern University Chicago, Illinois, United States
  • Montefiore Medical Center-Einstein Campus The Bronx, New York, United States
  • University of Pittsburgh Cancer Institute (UPCI) Pittsburgh, Pennsylvania, United States
View Trial Details
Active, Not Recruiting

Placebo-controlled, Study of Concurrent Chemoradiation Therapy With Pembrolizumab Followed by Pembrolizumab and Olaparib in Newly Diagnosed Treatment-Naïve Limited-Stage Small Cell Lung Cancer (LS-SCLC) (MK 7339-013/KEYLYNK-013)

NCT04624204

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Lung Diseases, +9 more
Locations
  • Ironwood Cancer & Research Centers ( Site 0007) Chandler, Arizona, United States
  • Loma Linda University Cancer Center ( Site 0011) Loma Linda, California, United States
  • Georgetown University ( Site 0017) Washington D.C., District of Columbia, United States
  • Moffitt Cancer Center ( Site 0137) Tampa, Florida, United States
View all 187 locations
View Trial Details
Active, Not Recruiting

Study of Tarlatamab in Combination With YL201 With or Without Anti-programmed Death Ligand 1 (PD-L1) in Participants With Extensive Stage (ES) Small Cell Lung Cancer (SCLC)

NCT06898957

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Lung Diseases, +8 more
Locations
  • City of Hope Orange County Lennar Foundation Cancer Center Irvine, California, United States
  • Yale New Haven Hospital New Haven, Connecticut, United States
  • Moffitt Cancer Center Tampa, Florida, United States
  • Dana Farber Cancer Institute Boston, Massachusetts, United States
View all 36 locations
View Trial Details
Active, Not Recruiting

Testing of Tazemetostat in Combination With Topotecan and Pembrolizumab in Patients With Recurrent Small Cell Lung Cancer

NCT05353439

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Extensive Stage Lung Small Cell Carcinoma, +13 more
Locations
  • Keck Medicine of USC Koreatown Los Angeles, California, United States
  • Los Angeles General Medical Center Los Angeles, California, United States
  • USC / Norris Comprehensive Cancer Center Los Angeles, California, United States
  • USC Norris Oncology/Hematology-Newport Beach Newport Beach, California, United States
View all 15 locations
View Trial Details

Related conditions